Expanded Medicare coverage for TCAR in standard surgical risk patients announced


Silk Road Medical today announced that the Centers for Medicare and Medicaid Services (CMS), through collaboration with the Society of Vascular Surgery’s Patient Safety Organization (SVS PSO) and their Vascular Quality Initiative (VQI), has expanded coverage for TCAR to include standard surgical risk patients within the SVS VQI TransCarotid Revascularization Surveillance Project.

This decision is effective immediately and comes on the heels of the recent Food and Drug Administration (FDA) approval for expanded indications for the Enroute stent system to include patients at high risk and standard risk for adverse events from carotid endarterectomy (CEA), the company explained in a press release.

The TCAR surveillance project is a prospective, national, open-ended observational registry designed to monitor the safety and effectiveness of transcarotid stents placed directly into the carotid artery while reversing blood flow to reduce stroke risk. Reimbursement for TCAR within the project will now apply to Medicare beneficiaries who are deemed to be at high and standard surgical risk for adverse events from CEA, Silk Road added.


Please enter your comment!
Please enter your name here